Healthcare -
Biotechnology - NASDAQ - US
$ 1.085
-12.8 %
$ 247 M
Market Cap
-4.36
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Gossamer Bio, Inc.
| Revenue | 115 M |
| Cost Of Revenue | 4.15 M |
| Gross Profit | 111 M |
| Operating Expenses | 175 M |
| Operating Income | -59.9 M |
| Other Expenses | -3.39 M |
| Net Income | -56.5 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 114.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 4.2 | 4.4 | 4.4 | 5.2 | 4.3 | 3.1 | 0.3 | 0 | 0 |
| Gross Profit | 110.5 | (4.4) | (4.4) | (5.2) | (4.3) | (3.1) | (0.3) | 0 | 0 |
| OPERATING INCOME | |||||||||
| Operating Expenses | 174.6 | 183.8 | 218.5 | 216.0 | 210.6 | 182.5 | 99.3 | 1.2 | 83 K |
| Selling, General and Administrative Expenses | 36.1 | 38.5 | 47.6 | 45.8 | 49.7 | 39.1 | 44.1 | 0.3 | 83 K |
| Research and Development Expenses | 138.5 | 145.3 | 170.9 | 170.3 | 160.9 | 143.4 | 55.3 | 0.9 | 0 |
| Operating Income | (59.9) | (183.8) | (218.6) | (216.1) | (234.0) | (186.1) | (149.0) | (6.7) | 83 K |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 11.5 | 13.5 | 13.9 | 19.4 | 12.7 | 0 | 12 K | 0.1 | 0 |
| Total Other Income | 4.3 | 3.9 | (10.8) | (17.9) | (9.4) | 5.8 | 2.0 | (0.1) | 0 |
| Pre-Tax Income | (55.6) | (179.8) | (229.4) | (234.0) | (243.4) | (180.3) | (147.0) | (6.8) | 83 K |
| NET INCOME | |||||||||
| Tax Provision | 0.9 | 0 | 10.8 | 15.1 | 8.2 | 0.5 | 2.0 | (5.4) | 83 K |
| Net Income | (56.5) | (179.8) | (240.2) | (249.1) | (251.6) | (180.8) | (147.0) | (6.8) | 83 K |
| EPS | 0.25 | 1.18 | 2.84 | 3.33 | 3.67 | 3.3 | 2.43 | 0.27 | 0.0033 |